Hoth Therapeutics, Inc.
HOTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,769 | $4,909 | $9,341 | $14,738 |
| - Cash | $7,039 | $9,292 | $6,429 | $8,538 |
| + Debt | $31 | $55 | $0 | $0 |
| Enterprise Value | -$2,239 | -$4,328 | $2,912 | $6,200 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $27 | -$153 | $0 | -$14,101 |
| % Margin | – | – | – | – |
| Net Income | -$8,188 | -$7,845 | -$11,372 | -$14,314 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.28 | -2.3 | -9.5 | -16.03 |
| % Growth | 44.3% | 75.8% | 40.7% | – |
| Operating Cash Flow | -$6,978 | -$8,447 | -$9,298 | -$12,090 |
| Capital Expenditures | $0 | $0 | -$74 | -$117 |
| Free Cash Flow | -$6,978 | -$8,447 | -$9,372 | -$12,207 |